KYOWA HAKKO KIRIN CO., LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 19587
 
  
 
C07K PEPTIDES 11840
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 7493
 
  
 
C07D HETEROCYCLIC COMPOUNDS 55107
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 4554
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 19187
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1481
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1386
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS1137
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 10128

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0042,910 THERAPEUTIC AGENT FOR FRONTAL LOBE DYSFUNCTIONMar 18, 16Feb 15, 18[A61K]
2018/0016,346 BISPECIFIC ANTIBODY BINDING TO TRAILR2 AND PSMAJan 08, 16Jan 18, 18[G01N, C07K]
2017/0349,532 CATIONIC LIPIDAug 18, 17Dec 07, 17[A61K, C07D, C12N, C07C]
2017/0335,016 STABLE MULTIVALENT ANTIBODYAug 07, 17Nov 23, 17[A61K, C07K]
2017/0266,255 PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING FRIZZLED1, FRIZZLED2 OR FRIZZLED7 EXTRACELLULAR CYSTEINE-RICH DOMAINMay 31, 17Sep 21, 17[A61K, A01K, C07K]
2017/0247,449 THERAPEUTIC METHOD AND MEDICAMENT FOR CANCER PATIENTS BY FOLR1-TARGETING DRUG AND AN ANTAGONIST FOR FOLIC ACID METABOLISMJun 05, 15Aug 31, 17[A61K, C07K]
2017/0247,700 NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF BETA-2GPIMay 13, 17Aug 31, 17[C12N]
2017/0247,701 NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF BETA-2GPIMay 13, 17Aug 31, 17[A61K, C12N]
2017/0240,647 METHOD OF MODULATING THE ACTIVITY OF FUNCTIONAL IMMUNE MOLECULESMar 16, 17Aug 24, 17[C12P, C07K]
2017/0198,262 CULTURE MEDIUM AND CULTURING METHOD FOR ANCHORAGE-DEPENDENT CELLS, CELL COMPOSITION INCLUDING STEM CELLS AND/OR DIFFERENTIATED CELLS DERIVED FROM STEM CELLS, AND PRODUCTION METHOD FOR CELL COMPOSITIONMay 28, 15Jul 13, 17[C12N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920028 Cationic lipidJul 01, 16Mar 20, 18[A61K, C07D, C12N, C07C]
9913907 RNAi pharmaceutical composition for suppressing expression of KRAS geneJul 16, 13Mar 13, 18[A61K, C12N]
9861577 Orally disintegrating tabletAug 31, 11Jan 09, 18[A61K]
9845306 Cationic lipidAug 18, 15Dec 19, 17[A61K, C07D, C12N, C07C]
9839616 Lipid nano particles comprising cationic lipid for drug delivery systemDec 12, 12Dec 12, 17[A61K, C12N, C07C]
9771351 Wnt signaling inhibitorJul 29, 14Sep 26, 17[C07D]
9771419 Antagonistic human light-specific human monoclonal antibodiesFeb 02, 15Sep 26, 17[A61K, C07K]
9757344 Fine particles coated with lipid membraneFeb 01, 10Sep 12, 17[A61K, B01J]
9758594 Stable multivalent antibodyApr 27, 09Sep 12, 17[A61K, C07K]
9725750 Protein production methodApr 17, 15Aug 08, 17[C12Q, C12P, C12N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0333,346 NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF BETA-2GPIAbandonedJan 16, 15Nov 17, 16[C12N]
2016/0008,362 AGENT FOR PREVENTING AND/OR TREATING OCULAR INFLAMMATORY DISEASEAbandonedMar 03, 14Jan 14, 16[A61K]
2015/0158,945 DNA ENCODING AN ANTI-SYSTEM ASC AMINO ACID TRANSPORTER 2 (ASCT2) ANTIBODYAbandonedOct 29, 14Jun 11, 15[C07K]
2015/0133,439 QUINAZOLINE DERIVATIVES AS KINASE INHIBITORSAbandonedJul 09, 14May 14, 15[C07D]
2015/0119,585 STEROL DERIVATIVEAbandonedDec 30, 14Apr 30, 15[C07J]
2014/0371,207 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOFAbandonedDec 13, 13Dec 18, 14[C07D]
2014/0330,004 OLIGONUCLEOTIDEAbandonedDec 06, 13Nov 06, 14[C12N]
2014/0249,166 METHODS OF TREATING PATIENTS SUFFERING FROM MOVEMENT DISORDERSAbandonedMar 27, 14Sep 04, 14[A61K]
2014/0221,340 CHEMOKINE RECEPTOR ACTIVITY REGULATORAbandonedAug 31, 12Aug 07, 14[C07D]
2014/0212,409 METHOD FOR INCREASING DEPOSITION OF COMPLEMENT C3b ON BACTERIAL SURFACE AND PHAGOCYTOSIS BY PHAGOCYTE AND A THERAPEUTIC METHOD AND A THERAPEUTIC AGENT FOR BACTERIAL INFECTIONSAbandonedAug 13, 13Jul 31, 14[C07K]
2014/0134,730 METHOD FOR INHIBITING CELL PROLIFERATION BY OXIDATIVE STRESSAbandonedOct 24, 13May 15, 14[C07K]
2014/0039,034 COMPOSITION FOR SUPPRESSING EXPRESSION OF TARGET GENEAbandonedFeb 02, 11Feb 06, 14[A61K]
2013/0337,505 MONOCLONAL ANTIBODY CAPABLE OF BINDING TO HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTORAbandonedMar 23, 12Dec 19, 13[C07K]
2013/0280,305 CATIONIC LIPIDAbandonedNov 02, 12Oct 24, 13[A61K, C07D, C07C]
2013/0274,252 QUINAZOLINE DERIVATIVES AS KINASE INHIBITORSAbandonedNov 02, 12Oct 17, 13[C07D]
2013/0224,295 GRANULE AND ORALLY-DISINTEGRATING TABLET CONTAINING DRUG CAUSING BITTERNESSAbandonedApr 08, 11Aug 29, 13[A61K]
2013/0225,581 NITROGEN-CONTAINING AROMATIC HETEROCYCLIC DERIVATIVEAbandonedJul 15, 11Aug 29, 13[C07D]
8501914 Recombinant protein S compositionExpiredAug 13, 09Aug 06, 13[A61K, C12P]
8481039 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factorExpiredFeb 03, 12Jul 09, 13[A61K, C12P, C07K]
2013/0129,811 CATIONIC LIPIDAbandonedApr 28, 11May 23, 13[A61K, C07D, C07C]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.